Blog

 

■ Fibrilação atrial

J Fernandes Neto, H T Moreira, C H Miranda et al

Revista Qualidade HC julho 2018/FMRP-USP/Ribeirão Preto

http://www.hcrp.usp.br/revistaqualidade/uploads/Artigos/183/183.pdf

 

■ Screening for atrial fibrillation with electrocardiography – Evidence report and systematic review for the US Preventive Service Task Force

D E Jonas, L C Kahwati, J D Y Yun et al

JAMA 2018, vol 320 (5): 485-498

https://jamanetwork.com/journals/jama/fullarticle/2695677

 

■ Ablation of atrial fibrillation: facts for the referring physician

A R M Sridhar, O Wazni, A A Hussein

Cleveland Clinic Journal of Medicine 2018, vol 85 (10): 789-799

https://www.mdedge.com/ccjm/article/175643/cardiology/ablation-atrial-fibrillation-facts-referring-physician

 

■ Ablação de Fibrilação Atrial Paroxística em Mulheres: Compreendendo a Diferença entre os Gêneros

Odozynski, Gabriel et al

Arq. Bras. Cardiol., May 2018, vol.110, no.5, p.449-454

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2018000500449&lng=pt&nrm=iso&tlng=pt

 

■ Atrial fibrillation ablation in patients with heart failure: on sive does not fit all

Rahul K Mukherjee, Steven E Williams, Steven A Niederer, Mark D O’Neill

Arrhythm Electrophysiol Rev. 2018 Jun; 7(2): 84–90

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020180

 

■ Atrioventricular nodal catheter ablation in atrial fibrillation complicating congestive heart failure

Osmar Antonio Centurión, Karina Elizabeth Scavenius, Laura B. García, Luis Miño, Judith Torales, Orlando Sequeira

J Atr Fibrillation. 2018 Jun-Jul; 11(1): 181

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207238/

 

■ 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation

Hugh Calkins, Gerhard Hindricks, Riccardo Cappato et al

Europace. 2018, vol 20(1): e1–e16

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834122/

 

■ Practical techniques in cryoballon ablation: Howe to isolate inferior pulmonary veins?

Shaojie Chen, Boris Schmidt, Stefano Bordignon et al

Arrhythm Electrophysiol Rev. 2018 Mar; 7(1): 11–17

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889812/

 

■ How to prevent, detect and manage complications caused by cryoballoon ablation of atrial fibrillation?

Nitin Kulkarni, Wilber Su, Richard Wu

Arrhythm Electrophysiol Rev. 2018 Mar; 7(1): 18–2

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889802/

 

■ Direct oral anticoagulants for stroke prevention in atrial fibrillation: treatment outcomes and dosing in special populations

Zachary A. Stacy, Sara K. Richter

Ther Adv Cardiovasc Dis. 2018 Sep; 12(9): 247–26

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116754/

 

■ Atrial fibrillation and cryptogenic stroke: What is the current evidence: Role of electrocardiographic monitoring

R Carmona-Puerta, Y Castro-Torres

J Arrhythm 2018, vol 34 (1): 1-3

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828277/

 

■ Atrial fibrillation in hypertrophic cardiomyopathy: diagnosis and considerations for management

Monica Patten, Simon Pecha, Ali Aydin

J Atr Fibrillation. 2018, vol 10(5): 1556.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006972/

 

■ Risk factor management in atrial fibrillation

Axel Brandes, Marcelle D Smit, Bao Oanh Nguyen, Michiel Rienstra, Isabelle C Van Gelder

Arrhythm Electrophysiol Rev. 2018 Jun; 7(2): 118–12

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020195/

 

■ Oral anticoagulant in chronic kidney disease and atrial fibrillation: the use of non-vitamin K-dependent anticoagulants and vitamina K antagonists

Gunnar H. Heine, Vincent Brandenburg, Stephan H. Schirmer

Dtsch Arztebl Int. 2018 Apr; 115(17): 287–294

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5974258/

 

■ Digoxin for atrial fibrillation and atrial flutter: a systematic review with meta-analysis and trial sequential analysis of randomised clinical trials

Naqash J. Sethi, Emil E. Nielsen, Sanam Safi et al

PLoS One. 2018;  vol 13(3): e0193924

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843263/

 

■ Periprocedural anticoagulation in atrial fibrillation: update on electrical crdioversion and ablation

1. P. G. van Vugt, M. A. Brouwer

Neth Heart J. 2018, vol 26(6): 352–360

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968006/

 

■ Mechanisms of atrial fibrillation in athletes: What we know and what we do not know?

1. Guasch, L. Mont, M. Sitges

Neth Heart J. 2018 vol 26(3): 133–145

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818379/

 

■ Management of atrial fibrillation-flutter: uptodate guideline paper on the current evidence

Syed Raza Shah, Sue-Wei Luu, Matthew Calestino et al

J Community Hosp Intern Med Perspect. 2018; vol 8(5): 269–275

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197036/

 

■ Atrial arrhythmias in pulmonary hypertension: pathogenesis, prognosis and management

Brett Wanamaker, Thomas Cascino, Vallerie McLaughlin et a

Arrhythm Electrophysiol Rev. 2018 Mar; 7(1): 43–48

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889803/

 

■ Treatment of atrial fibrillation in patients with co-existing heart failure and reduced ejection fraction: Time to revisit the management guidelines?

Alex Baher, Nassir F Marrouche

Arrhythm Electrophysiol Rev. 2018 Jun; 7(2): 91–94

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020176/

 

■ Age maker a differences: symptoms in pediatric supraventricular tachycardia

A Quattrocelli, J Lang A Davis, A Pflaumer

J Arrhythm 2018, vol 34 (5): 565-571

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174476/

 

■ Source determination in atrial fibrillation

Rakesh Latchamsetty, Fred Morady

Arrhythm Electrophysiol Rev. 2018 Aug; 7(3): 165–16

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141915/

 

■ Systematic screening for atrial fibrillation in the community: evidence and obstacles

Ngai-Yin Chan

Arrhythm Electrophysiol Rev. 2018 Mar; 7(1): 39–42

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889810/

 

■ Inflammation and atrial fibrillation: a comprehensive review

P Korantzopoulos, K P Letsas, G Tse et al

J Arrhythm 2018, vol 34 (4): 394-401

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111477/

 

■ Management and disposition of atrial fibrillation in the emergency department: a systematic review

Justin L. Vandermolen, Murrium I. Sadaf, Anil K. Gehi

J Atr Fibrillation. 2018 Jun-Jul; 11(1): 1810

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207234/

 

 

by Dr Paulo Fernando Leite

■ Cardiologia/Prevenção Cardiovascular

■ Estratificação de Risco Cardiovascular

Av Contorno 8351 – Conj 01

Belo Horizonte/MG/Brasil

Tel: 31 32919216   2917003   3357229

(- consulta particular –)

CRMMG: 7026

Email: pfleite1873@gmail.com

 

■ Correlação entre exercício físico e qualidade de vida em pacientes com doença de Alzheimer

M Kamada, J S Clemente, A F F Monteiro et al

Rev Soc Bras Clin Med 2018, vol 16 (2): 119-122

http://docs.bvsalud.org/biblioref/2018/09/913374/162119-122.pdf

 

■ Cognitive, functional and physical activity impairment in elderly with Alzheimer’s disease.

Pedroso, Renata Valle et al.

Dement. neuropsychol., Mar 2018, vol.12, no.1, p.28-34

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642018000100028&lng=en&nrm=iso&tlng=en

 

■ Assessing fitness to drive in patients with different types os dementia

Dafne Piersma, Anselm B.M. Fuermaier, Dick De Waard et al

Alzheimer Dis Assoc Disord. 2018, vol 32(1): 70–75

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841853/

 

■ Alzheimer´s disease and blood-based biomarkers – potential contexts of use

Martina Zvěřová

Neuropsychiatr Dis Treat. 2018; 14: 1877–1882

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055879/

 

■ Cognitive blackouts in mild cognitive impairment and Alzheimer´s dementia

Georg Adler, Agnies Marczak, Jana Binder

Dement Geriatr Cogn Dis Extra. 2018 Jan-Apr; 8(1): 72–76

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869359/

 

■ Alzheimer dementia: starting stopping drug therapy

L D Kim R M Factora

Cleveland Clinic Journal of Medicine 2018, vol 85: 209-214

https://www.mdedge.com/ccjm/article/159356/geriatrics/alzheimer-dementia-starting-stopping-drug-therapy

 

■ Ocular manifestation of Alzhemier´s and other neurodegenerative diseases: the prospect of the eye as a tool for the early diagnosis of Alzheimer´s disease

P Colligris, M J P de Lara, B Colligris, J Pintor

Journal of Ophthalmology 2018, Article ID 8538573, 12 pages

https://www.hindawi.com/journals/joph/2018/8538573/

 

■ Strategies for continued successful treatment in patients with Alzheimer´s disease: an overview of switching between pharmacological agents

Rafael Blesa, Kazuhiro Toriyama, Kengo Ueda et al

Curr Alzheimer Res. 2018 Oct; 15(10): 964–974

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142408/

 

■ Associations of acetylcholinesterase inhibitor treatment with reduced mortality in Alzheimer´s disease: a retrospective survival analysis

C Mueller, G Perera, R D Hayes et AL

Age and Ageing 2018, vol 47 (1): 88-94

https://academic.oup.com/ageing/article/47/1/88/3887242

 

■ Health economic evalutations of non-pharmacological interventions for persons with dementia and their informal caregivers: a systematic review

Franziska Nickel, Janina Barth, Peter L. Kolominsky-Rabas

BMC Geriatr. 2018; 18: 69

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845149/

 

■ Technology-based cognitive training and rehabilitation inverventions for individuals with cognitive impairment: a systematic review

Shaoqing Ge, Zheng Zhu, Bei Wu, Eleanor S. McConnell

BMC Geriatr. 2018; 18: 213

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139138/

 

■ National dementia strategies: What should Canada Learn?

Selina Chow, Ronald Chow, Angela Wan et al

Can Geriatr J. 2018 Jun; 21(2): 173–209

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028171/

 

■ Psychosocial interventions for Alzhemier´s disease cognitive symptoms: a Bayesian network meta-analysis

Y Duan, L Lu, J Chen et al

BMC Geriatrics 2018, vol 18: 175

https://bmcgeriatr.biomedcentral.com/articles/10.1186/s12877-018-0864-6

 

■ Systematic Review on resting-state EEC for Alzheimer´s disease diagnosis and progression assessment

Raymundo Cassani, Mar Estarellas, Rodrigo San-Martin et al

Dis Markers. 2018; 2018: 5174815

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200063/

 

■ Flavonoids as therapeutic agents in Alzheimer´s and Parkinsons diseases: a systematic review of preclinical evidences

Roxana Braga de Andrade Teles, Tâmara Coimbra Diniz, Tiago Coimbra Costa Pinto et al

Oxid Med Cell Longev. 2018; 2018: 7043213

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5971291/

 

■ Neuroing characteristics of small-vessel disease in older adults with normal cognition, mild cognitive  impairment, and Alzheimer disease

Alberto Mimenza-Alvarado, Sara G. Aguilar-Navarro, Sara Yeverino-Castro et al

Dement Geriatr Cogn Dis Extra. 2018, vol 8(2): 199–206

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006607/

 

■ Low expression of aging-relatedd NRXN3 is associated with Alzheimer disease

J Zheng, W Li, J Liu et al

Medicine (Baltimore) 2018, vol 97 (28): e11343

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076205/

 

■ Validity and reliability of the Brazilian Portuguese version of the Australian National University – Alzheimer’s Disease Risk Index (ANU-ADRI).

Borges, Marcus Kiiti, Jacinto, Alessandro Ferrari and Citero, Vanessa Albuquerque

Dement. neuropsychol., Sept 2018, vol.12, no.3, p.235-243

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642018000300235&lng=en&nrm=iso&tlng=en

 

■ Olfactory dysfunction in Alzheimer’s disease Systematic review and meta-analysis.

Silva, Maren de Moraes e et al.

Dement. neuropsychol., June 2018, vol.12, no.2, p.123-132

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642018000200123&lng=en&nrm=iso

 

■ Visual features in Alzheimer´s disease: from basic mechanism to clinical overview

M A Cerquera-Jaramillo, M O Nava-Mesa, R E González-Reyes et al

Neural Plasticity 2018, Article ID 2941783, 21 pages

https://www.hindawi.com/journals/np/2018/2941783/

 

■ Factors associated with quality of life in patients with Alzheimer´s disease

Coralie Barbe, Damien Jolly, Isabella Morrone et al

BMC Geriatr. 2018; 18: 159.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038200/

 

by Dr Paulo Fernando Leite

■ Cardiologia/Prevenção Cardiovascular

■ Estratificação de Risco Cardiovascular

Av Contorno 8351 – Conj 01

Belo Horizonte/MG/Brasil

Tel: 31 32919216   2917003   3357229

(- consulta particular –)

CRMMG: 7026

Email: pfleite1873@gmail.com